Skip to main content

Publications

3 publications

Funding

3 grants

Active

3 grants
  • KP
    Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) Consortium
    National Institute of Allergy and Infectious Diseases · 2024–2029 · via University of California, San Francisco
    UM1AI179699-01
  • KP
    Conditional Mtb knockdown mutants for TB drug discovery
    Bill & Melinda Gates Foundation · 2023–2026
    BMGF INV-055896
  • KP
    Harnessing B Cells For TB Vaccine Development To Improve Therapy Of TB And TB-HIV Coinfection
    National Institute of Allergy and Infectious Diseases · 2021–2026 · via Center for Discovery and Innovation
    R01AI161013-01